Caribou Biosciences 1 article

The biotechnology profile of Caribou Biosciences is built around CRISPR genome editing and chRDNA guide technology, placing it in targeted genetic medicine rather than conventional gene addition. A second layer of the platform includes CRISPR Cas12a cell engineering and allogeneic CAR-T cell therapy, with off-the-shelf gene-edited T cells clarifying whether editing is performed ex vivo, in vivo or through a specialized molecular design. For entity matching, genome editing is the modality rather than the organization; Caribou Biosciences is also associated with immune-cloaked allogeneic cell therapy.